OakChart

Neuronetics Inc

STIMHealthcare·Medical Devices·USA·Micro·NASD·Nov 11 • 8:57 AM ET

1.73-0.28 (-13.93%)
2026-11-11 14:58 CET
Market cap
156.23 USD m
Revenue, TTM
159.76 USD m
Net income, TTM
-23.08 USD m
Free cash flow, TTM
-9.58 USD m
EPS diluted, TTM
-0.33
P/E
-
Compare

Price

STIM against its 20, 50 and 200-day averages
2050200beat
1.002.003.0014.6M29.1MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26STIMclose 1.7320-day 2.1450-day 2.40200-day 1.881.73

49.7% under 3.44 on 11 Aug 2026. Last 15 sessions, 82.6% high to low

Profile

STIM
52-week range, 35% of the way up
0.803.44

Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. It operates through United States and International geographical segments. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon, and Thomas D. Weldon in 2003 and is headquartered in Malvern, PA.

Employees658
IPOJun 28, 2018
Beta1.34
ATR, 14d0.26
Rel volume2.70
Short float22.61%
Insider own62.10%
Inst own29.60%

Snapshot

6 groups

Valuation

Index-
Market Cap134.47M
Enterprise Value197.78M
Income-23.08M
Sales159.76M
Book/sh0.24
Cash/sh0.36
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees658
IPOJun 28, 2018

Ratios

P/E-
Forward P/E-
PEG-
P/S0.84
P/B7.19
P/C4.78
P/FCF-
EV/EBITDA-
EV/Sales1.24
Quick Ratio1.82
Current Ratio2.01
Debt/Eq4.69
LT Debt/Eq4.42
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.33
EPS next Y-0.24
EPS next Q-0.07
EPS this Y50.54%
EPS next Y17.59%
EPS next 5Y30.48%
EPS past 3/5Y24.64% 16.51%
Sales past 3/5Y31.76% 24.81%
EPS Y/Y TTM60.22%
Sales Y/Y TTM23.01%
EPS Q/Q83.63%
Sales Q/Q12.51%
EarningsNov 04 BMO
EPS/Sales Surpr.72.34% 2.97%

Ownership

Insider Own62.10%
Insider Trans1.35%
Inst Own29.60%
Inst Trans-9.84%
ROA-16.64%
ROE-100.20%
ROIC-22.76%
Gross Margin49.47%
Oper. Margin-9.39%
Profit Margin-14.45%
SMA20-19.10%
SMA50-28.02%
SMA200-7.89%
Trades-

Technical

Shs Outstand77.73M
Shs Float29.46M
Short Float22.61%
Short Ratio3.90
Short Interest6.66M
52W High3.44 -49.71%
52W Low0.80 116.25%
Volatility18.29% 10.15%
ATR (14)0.26
RSI (14)37.22
Beta1.34
Rel Volume2.70
Avg Volume1.71M
Volume230,350

Performance

Perf Week-36.04%
Perf Month-13.07%
Perf Quarter-42.90%
Perf Half Y14.57%
Perf YTD25.36%
Perf Year-21.36%
Perf 3Y36.22%
Perf 5Y-67.66%
Perf 10Y-
Recom1.00
Target Price6.00
Prev Close2.01
Price1.73
Change %-13.93%

Analyst ratings

latest 8 of 8
DateActionAnalystRating changeTargetImplied
Sep 11, 2026InitiatedRB. Riley SecuritiesBuy$5+189.0%
Jul 20, 2026InitiatedBBTIG ResearchBuy$5+189.0%
Aug 13, 2024DowngradeWWilliam BlairOutperform → Mkt Perform
Oct 13, 2021DowngradeWWilliam BlairOutperform → Mkt Perform
Oct 13, 2021DowngradeBBTIG ResearchBuy → Neutral
Jan 22, 2021UpgradeWWilliam BlairMkt Perform → Outperform
Feb 06, 2020InitiatedBBTIG ResearchBuy$11+535.8%
Jul 24, 2018InitiatedCCanaccord GenuityBuy

Peers

Mkt cap
TickerCompanyMkt cap
BWAYBrainsway Ltd ADR429.47M
ECORElectroCore Inc71.22M
MOBIMobia Medical Inc406.60M
NPCENeuroPace Inc435.57M
LIVNLivaNova PLC4.96B
CLPTClearPoint Neuro Inc292.38M
NXLNexalin Technology Inc1.69M
CMPSCompass Pathways Plc ADR1.36B
LFSTLifeStance Health Group Inc5.51B
ACHCAcadia Healthcare Company Inc3.59B

Insider trading

latest 14 of 38
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Anderson CoryOfficerNov 10 '26Proposed Sale2.075,13710,655Nov 10 03:36 PM
Chernett Jorey10% OwnerOct 30 '26Buy2.2718,00040,86010,620,988Nov 02 08:49 AM
MACAN WILLIAM ANDREWFormer OfficerAug 19 '26Proposed Sale3.10149,891463,934Aug 19 02:13 PM
MACAN WILLIAM ANDREWOfficerAug 18 '26Proposed Sale3.21121,033388,274Aug 18 04:46 PM
Chernett Jorey10% OwnerAug 14 '26Buy3.1614,00044,24010,602,988Aug 17 10:13 AM
Chernett Jorey10% OwnerJul 14 '26Buy1.7835,00062,30010,588,988Jul 15 09:33 AM
Sullivan Keith JFormer Officer and DirectorJun 08 '26Proposed Sale1.2942,16454,345Jun 08 04:38 PM
Chernett Jorey10% OwnerMay 19 '26Buy1.17100,000117,00010,553,988May 20 12:39 PM
Chernett Jorey10% OwnerMay 12 '26Buy1.34475,000636,50010,453,988May 13 08:31 AM
Chernett Jorey10% OwnerApr 20 '26Buy1.58100,000158,0009,878,988Apr 22 09:39 AM
Chernett Jorey10% OwnerApr 21 '26Buy1.51100,000151,0009,978,988Apr 22 09:39 AM
Chernett Jorey10% OwnerMar 30 '26Buy1.25385,442481,8029,778,988Mar 30 07:41 PM
Chernett Jorey10% OwnerMar 27 '26Buy1.35500,000675,0009,393,276Mar 30 09:37 AM
Chernett Jorey10% OwnerMar 25 '26Buy1.40125,000175,0008,868,276Mar 27 09:33 AM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
PSILAdvisorShares Psychedelics ETFAUM: 43.26M
VXFVanguard Extended Market Index ETFAUM: 30.47B
BUSMEA Bridgeway Ultra-Small Company Market ETFAUM: 111.21M
IWCiShares Micro-Cap ETFAUM: 1.22B
QQQSInvesco NASDAQ Future Gen 200 ETFAUM: 20.53M

News

latest 14 of 206
  • Neuronetics Announces Pricing of $30 Million Underwritten Public Offering of Common Stock (GlobeNewswire) -7.80% -13.93%
  • Neuronetics stock tumbles 10% on stock offering launch (Investing.com)
  • Neuronetics Announces Proposed Public Offering of Common Stock (GlobeNewswire)
  • Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +19.69% -10.17%
  • Neuronetics Posts First GAAP Operating Profit And Raises Margin Outlook, But A Held Revenue Guide And Thin Cash Keep The Turnaround On Probation (Earnings Whispers)
  • Loading…
  • Neuronetics Reports 12.5% Revenue Growth to $42 Million in Q3 2026 as Losses Narrow (InvestorsHub)
  • Neuronetics: Q3 Earnings Snapshot (Associated Press)
  • Neuronetics Reports Third Quarter 2026 Financial and Operating Results (GlobeNewswire)
  • Neuronetics Must Prove Its Profit Pivot Holds As Neurostar Revenue Turns Choppier (Earnings Whispers)
  • Neuronetics to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call (GlobeNewswire)
  • NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System (GlobeNewswire)
  • Neuronetics Inc (STIM) (Q2 2026) Earnings Call Highlights: Revenue Growth and Margin Expansion ... (GuruFocus.com) +47.00%
  • Neuronetics Narrows Q2 Loss as Greenbrook Growth Drives 9% Revenue Increase (InvestorsHub)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-04-0.020-0.072-0.02041.9640.754
2026Q22026-08-11-0.050-0.123-0.04741.5740.174
2026Q12026-05-05-0.160-0.174-0.15534.4534.173
2025Q42026-03-17-0.100-0.106-0.10441.7840.673
2025Q32025-11-04-0.130-0.125-0.13437.3037.813
2025Q22025-08-05-0.150-0.078-0.15338.1136.783
2025Q12025-05-06-0.210-0.124-0.20631.9829.074
2024Q42025-03-04-0.330-0.243-0.33222.4919.634
2024Q32024-11-12-0.440-0.229-0.44118.5319.144
2024Q22024-08-12-0.330-0.269-0.32716.4518.654
2024Q12024-05-07-0.270-0.310-0.26717.4217.124
2023Q42024-03-05-0.190-0.259-0.18520.3119.854
2023Q32023-11-07-0.330-0.310-0.32517.8817.584
2023Q22023-08-08-0.170-0.348-0.17117.6117.364
2023Q12023-05-09-0.380-0.388-0.37515.5415.184
2022Q42023-03-07-0.300-0.380-0.30518.2016.824

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-1.580-1.614-1.58062.6662.24
2020FY-1.460-1.506-1.45849.2448.07
2021FY-1.220-1.238-1.22455.3154.37
2022FY-1.380-1.456-1.38165.2163.82
2023FY-1.050-1.130-1.05371.3570.89
2024FY-1.370-1.270-1.37774.8972.03
2025FY-0.590-0.595-0.590149.16148.09
2026FY--0.292--162.3
2027FY--0.241--176.95
2028FY--0.198--192.37
2029FY--0.140--210.9
2030FY--0.095--229.05

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0440444.3044.0044.50
2026Q4S2026-11-0240145.1544.3046.30
2026Q4S2026-10-2540045.6045.0046.30
2026Q4S2026-10-0941245.6045.0046.30
2026Q4S2026-09-1641245.5944.9746.30
2026Q4S2026-09-0941245.6045.0046.30
2026Q4S2026-08-1131245.4345.0046.30
2026Q4S2026-07-1940045.6445.1646.00
2026Q4S2026-07-1741045.6445.1646.00
2026Q4S2026-07-1641045.6445.1646.00
2026Q4S2026-05-3131045.5545.1646.00
2026Q4S2026-05-2732045.5545.1646.00
2026Q4S2026-05-1233045.5545.1646.00
2026Q4S2026-05-1133045.5545.1646.00

Estimate history

EPS, annual-0.914-2.693-1.58-1.458-1.224-1.381-1.053-1.377-0.591-0.3282
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.441-0.332-0.206-0.153-0.134-0.104-0.155-0.047-0.022
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual40.43352.77662.65649.24455.31265.20671.34874.89149.157159.76
Period201720182019202020212022202320242025TTM
Sales, quarterly18.5322.49331.97538.10837.29741.77734.45441.56841.962
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual17.57117.74418.64519.11426.39527.26829.09255.67968.99477.728
Period201720182019202020212022202320242025MRQ
Shares, quarterly30.31755.67965.8266.11368.44568.99469.58376.19377.728
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue159.76149.1674.8971.3565.2155.3149.2462.6652.78
Cost of Goods Sold Incl. D&A80.7378.3522.8021.6517.1312.7112.4915.3912.45
Gross Profit79.0370.8152.0949.7048.0842.6036.7547.2740.33
Selling, General and Administrative Excl. Other94.02102.2486.6580.2582.0968.5659.0674.2060.16
Research and Development5.566.5812.779.529.347.929.2013.758.23
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-15.00-31.44-34.56-30.55-34.01-25.96-22.31-26.93-19.83
Interest Expense8.858.417.295.424.254.024.523.693.69
Unusual Expense0.540.004.430.001.101.600.92-1.40
Net Income Before Taxes-23.01-39.13-43.73-30.19-37.16-31.19-27.45-29.04-24.10
Income Taxes0.000.000.000.000.000.000.000.000.00
Consolidated Net Income-23.01-39.13-43.73-30.19-37.16-31.19-27.45-29.04-24.10
Net Income From Continuing Operations-23.08-39.00-43.71-30.19-37.16-31.19-27.45-29.04-24.10
Net Income-23.08-39.00-43.71-30.19-37.16-31.19-27.45-29.04-24.10
EPS (Recurring)-0.29-0.59-1.28-1.05-1.35-1.18-1.42-1.58-2.58
EPS (Basic, Before Extraordinaries)-0.33-0.59-1.38-1.05-1.38-1.22-1.46-1.58-2.69
EPS (Diluted)-0.33-0.59-1.38-1.05-1.38-1.22-1.46-1.58-2.69
EBITDA-12.02-27.97-32.49-28.55-32.36-24.90-21.37-25.86-18.95
Non-Operating Income (Expense)1.380.722.555.792.200.390.301.570.82
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense4.726.855.607.328.757.874.403.431.74
Price To Sales Ratio1.130.610.681.162.832.054.251.323.28
Gross Margin49.4747.4769.5569.6673.7377.0274.6375.4476.42
Operating Margin-9.39-21.08-46.15-42.82-52.16-46.94-45.30-42.98-37.58
Net Margin-14.45-26.15-58.36-42.31-56.99-56.39-55.75-46.35-45.66
Shares Outstanding77.7368.9955.6829.0927.2726.3919.1118.6417.74
Market Capitalization156.23156.2351.6383.91187.01117.60210.8283.66340.15

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue41.9641.5734.4541.7837.3038.1131.9822.49
Cost of Goods Sold Incl. D&A20.4720.7519.0520.4721.0721.2517.158.04
Gross Profit21.4920.8215.4121.3016.2216.8614.8314.45
Selling, General and Administrative Excl. Other20.9522.3224.4026.3523.5424.9125.8425.40
Research and Development1.191.341.361.671.501.801.625.77
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income0.54-1.50-8.99-5.04-7.32-8.06-11.01-10.95
Interest Expense2.142.122.272.322.211.971.921.76
Unusual Expense0.000.000.540.000.000.000.000.00
Net Income Before Taxes-1.56-3.46-10.78-7.21-9.40-9.84-12.69-12.16
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-1.56-3.46-10.78-7.21-9.40-9.84-12.69-12.16
Net Income From Continuing Operations-1.69-3.44-10.79-7.16-9.04-10.12-12.68-12.16
Net Income-1.69-3.44-10.79-7.16-9.04-10.12-12.68-12.16
EPS (Recurring)-0.02-0.05-0.15-0.10-0.13-0.15-0.21-0.33
EPS (Basic, Before Extraordinaries)-0.02-0.05-0.15-0.10-0.13-0.15-0.21-0.33
EPS (Diluted)-0.02-0.05-0.15-0.10-0.13-0.15-0.21-0.33
EBITDA1.28-0.77-8.25-4.28-6.43-7.16-10.10-10.51
Non-Operating Income (Expense)0.050.161.020.150.130.190.250.55
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.180.691.682.181.411.811.441.28
Price To Sales Ratio1.130.610.670.641.412.082.530.79
Gross Margin51.2150.0944.7250.9943.4944.2346.3764.25
Operating Margin1.29-3.61-26.11-12.07-19.63-21.15-34.45-48.68
Net Margin-4.03-8.27-31.32-17.13-24.25-26.56-39.64-54.05
Shares Outstanding77.7376.1969.5868.9968.4466.1165.8255.68
Market Capitalization156.2390.46100.4594.51180.52229.71242.2051.63

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments34.1319.6660.5871.8896.3450.8476.59104.5829.15
Short Term Receivables17.1224.2917.8413.827.787.176.575.624.27
Inventories4.334.258.098.906.563.722.772.432.47
Other Current Assets5.979.927.284.174.653.282.521.841.12
Total Current Assets61.5558.1293.7998.77115.3365.0188.45114.4737.01
Net Property, Plant & Equipment28.0333.344.785.325.104.154.902.381.36
Total Investments and Advances0.100.090.661.221.702.331.730.000.00
Long-Term Note Receivable0.150.293.790.3610.11----
Intangible Assets41.7738.24-0.000.000.000.00--
Other Assets9.9510.8212.8011.218.987.175.080.170.57
Total Assets141.55140.90115.83116.88141.2278.66100.17117.0238.94
Short Term Debt Incl. Current Port. of LT Debt5.564.790.8413.950.670.5911.810.000.00
Accounts Payable10.7411.084.752.434.303.754.623.762.51
Income Tax Payable--------0.32
Other Current Liabilities14.2215.4014.2116.8210.739.3411.269.809.16
Total Current Liabilities30.5231.2719.8133.2015.7013.6827.6913.5611.99
Long Term Debt84.7477.8461.6325.8038.8737.7422.5230.3929.56
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities0.050.000.200.831.471.742.112.032.90
Total Liabilities115.31109.1081.6459.8256.0553.1652.3245.9844.45
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00187.14
Common Equity22.3827.7134.1957.0685.1725.4947.8571.04-192.65
Total Shareholders Equity22.3827.7134.1957.0685.1725.4947.8571.04-5.52
Accumulated Minority Interest3.864.090.000.000.000.000.000.000.00
Total Equity26.2431.8034.1957.0685.1725.4947.8571.04-5.52
Total Liabilities & Stockholders Equity141.55140.90115.83116.88141.2278.66100.17117.0238.94
Book Value Per Share0.320.501.182.093.231.332.574.00-10.96
Tangible Book Value Per Share-0.28-0.191.182.093.231.332.574.00-10.96
Full-Time Employees658716203194175126235140145
Price to Book Ratio8.355.202.212.951.388.331.754.834.37
Return on Assets-27.61-34.05-25.95-28.79-28.37-30.70-26.75-30.90-50.39
Return on Equity-155.73-141.23-66.17-52.25-56.37-74.86-48.86-73.55-
Return on Invested Capital-36.41-41.41-31.51-44.85-25.15-43.41-41.27-23.76-66.80
Quick Ratio1.871.724.332.716.934.483.098.262.88
Current Ratio2.021.864.732.987.344.753.198.443.09

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-23.01-39.13-43.73-30.19-37.16-31.19-27.45-29.04-24.10
Depreciation2.983.462.072.011.651.060.941.060.88
Other Funds (Non Cash)6.798.7217.4610.259.558.796.404.414.21
Funds from Operations-13.23-26.95-24.19-17.93-25.96-21.35-20.11-23.57-19.01
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital4.956.58-6.81-14.10-4.78-6.64-8.28-6.91-1.58
Cash from Operating Activities-8.28-20.37-31.00-32.04-30.74-27.98-28.39-30.48-20.59
Capital Expenditures-1.30-0.80-1.47-2.37-3.27-2.35-0.73-0.81-1.01
Net Assets From Acquisitions0.000.00-2.550.000.000.000.000.00-
Sale of Fixed Assets and Businesses0.030.000.000.000.000.000.000.00-
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.00-7.490.000.000.00
Other Sources0.000.001.611.0510.000.000.000.000.00
Cash from Investing Activities-1.27-0.80-2.41-1.326.73-9.84-0.73-0.81-1.01
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock10.2326.822.520.000.3083.010.692.4297.04
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock10.2326.822.520.000.3083.010.692.4297.04
Proceedsfrom Stock Options8.0326.810.000.000.0080.570.000.0096.53
Issuance or Reduction of Debt, Net-5.309.62-5.1422.700.000.001.680.000.00
Change in Long Term Debt-5.309.62-5.1422.700.000.001.680.000.00
Issuance of Long Term Debt-0.099.8354.8523.900.000.0040.540.000.00
Reduction of Long Term Debt-5.21-0.21-60.00-1.200.000.00-38.860.000.00
Net Financing Active Other Cash Flow-1.94-0.59-4.180.00-0.090.000.000.000.00
Other Financing Activities Uses-1.94-0.59-4.180.00-0.090.00-0.000.00
Cash from Financing Activities2.9435.85-6.8122.700.2183.012.372.4297.04
Net Change in Cash-6.6214.68-40.22-10.66-23.8045.18-26.75-28.8875.44
Free Cash Flow-9.58-21.18-32.46-34.41-34.01-30.34-29.12-31.30-21.60
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments28.1125.1819.2234.1334.6517.64
Short Term Receivables14.6916.2716.2117.1219.1926.64
Inventories4.945.504.714.334.324.94
Other Current Assets6.156.287.035.976.736.91
Total Current Assets53.8953.2347.1761.5564.8956.14
Net Property, Plant & Equipment27.8827.3826.9428.0329.1729.80
Total Investments and Advances0.090.070.110.100.090.10
Intangible Assets40.6841.0441.4141.7741.1837.96
Other Assets9.409.779.719.959.9110.31
Total Assets131.96131.53125.44141.55145.47134.65
Short Term Debt Incl. Current Port. of LT Debt5.045.145.425.565.585.32
Accounts Payable9.9612.4211.4310.7411.579.72
Other Current Liabilities11.8610.7511.4314.2211.7812.76
Total Current Liabilities26.8628.3128.2930.5228.9427.80
Long Term Debt82.6981.3879.9784.7485.1775.34
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.010.200.130.050.000.00
Total Liabilities109.56109.89108.38115.31114.11103.14
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity18.7117.8513.2722.3827.3627.15
Total Shareholders Equity18.7117.8513.2722.3827.3627.15
Accumulated Minority Interest3.693.793.793.864.004.36
Total Equity22.4021.6417.0626.2431.3631.51
Total Liabilities & Stockholders Equity131.96131.53125.44141.55145.47134.65
Book Value Per Share0.240.230.190.320.400.41
Tangible Book Value Per Share-0.28-0.30-0.40-0.28-0.20-0.16
Full-Time Employees---658--
Price to Book Ratio8.356.824.473.456.656.48
Return on Assets-16.64-22.87-27.76-27.61-40.07-41.73
Return on Equity-100.20-135.26-152.36-155.73-239.53-207.57
Return on Invested Capital-1.67-3.47-11.57-6.68-8.04-9.87
Quick Ratio1.821.691.501.872.091.84
Current Ratio2.011.881.672.022.242.02

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-1.56-3.46-10.78-7.21-9.40-9.84
Depreciation0.740.730.740.770.890.90
Other Funds (Non Cash)0.501.092.442.762.012.31
Funds from Operations-0.31-1.64-7.59-3.68-6.50-6.63
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital1.610.58-1.834.595.723.12
Cash from Operating Activities1.29-1.06-9.420.91-0.79-3.50
Capital Expenditures-0.47-0.42-0.20-0.22-0.11-0.25
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.030.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.47-0.42-0.17-0.22-0.11-0.25
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock2.797.580.00-0.147.980.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock2.797.580.00-0.147.980.00
Proceedsfrom Stock Options0.597.580.00-0.147.980.00
Issuance or Reduction of Debt, Net0.000.00-5.00-0.309.920.00
Change in Long Term Debt0.000.00-5.00-0.309.920.00
Issuance of Long Term Debt0.000.000.00-0.099.920.00
Reduction of Long Term Debt0.000.00-5.00-0.210.000.00
Net Financing Active Other Cash Flow-0.65-0.12-0.58-0.590.000.00
Other Financing Activities Uses-0.65-0.12-0.58-0.590.000.00
Cash from Financing Activities2.097.46-5.58-1.0317.900.00
Net Change in Cash2.915.98-15.17-0.3417.00-3.75
Free Cash Flow0.82-1.48-9.620.69-0.90-3.76

Revenue breakdown

Product2024: 70.45M 2025: 62.18M
Service2024: 4.45M 2025: 86.98M
United States2024: 74.89M 2025: 149.16M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3022.61%6.7M29.5M1.62M
2026-10-1524.97%7.2M28.9M1.99M
2026-09-3024.47%7.1M28.9M2.08M
2026-09-1521.50%6.2M28.9M2.21M
2026-08-3123.09%6.7M28.9M2.14M
2026-08-1427.87%8.0M28.9M2.46M
2026-07-3138.87%9.3M24.0M2.22M
2026-07-1538.21%9.4M24.5M2.02M
2026-06-3031.08%7.7M24.7M2.21M
2026-06-1539.67%9.8M24.7M2.42M
2026-05-2936.41%9.9M27.1M2.35M
2026-05-1535.02%9.6M27.5M2.12M
2026-04-3040.63%10.5M25.8M2.32M
2026-04-1544.06%10.9M24.8M2.23M
2026-03-3126.14%9.4M35.9M2.11M
2026-03-1326.09%9.4M35.9M1.82M
2026-02-2728.93%10.3M35.5M1.85M
2026-02-1323.67%8.4M35.5M2.10M
2026-01-3025.47%8.6M33.7M1.70M
2026-01-1519.76%7.2M36.2M1.67M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call0.501.202.102.0327.93713.000.000.954-0.0190.000
call1.000.701.701.8014.8112150.000.884-0.0210.001
call1.500.051.000.906.5781830.000.786-0.0180.001
call2.000.200.750.405.8911640.000.689-0.0350.001
call2.500.100.400.384.2565180.000.515-0.0290.001
call5.000.000.100.054.3032,0250.000.175-0.0190.001
call7.500.000.550.105.43514.000.000.152-0.0210.001
put0.500.001.000.0511.5836.000.00-0.046-0.0190.000
put1.000.001.000.006.2640.000.00-0.116-0.0210.001
put1.500.000.200.153.6081030.00-0.214-0.0180.001
put2.000.000.750.405.9951950.00-0.311-0.0350.001
put2.500.100.950.234.7342460.00-0.485-0.0280.001
put5.002.403.402.305.4597.000.00-0.825-0.0180.001
put7.503.507.504.450.0000.000.00-0.848-0.0210.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10144Filing for proposed sale of securities under Rule 144.SEC
2026-11-10424B5SEC
2026-11-108-KCurrent report2026-11-05SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-11-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-024Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-08-24SCHEDULE 13D/ASEC
2026-08-19144Filing for proposed sale of securities under Rule 144.SEC
2026-08-18144Filing for proposed sale of securities under Rule 144.SEC
2026-08-178-KCurrent report2026-08-11SEC
2026-08-174Statement of changes in beneficial ownership of securities2026-08-13SEC
2026-08-14SCHEDULE 13GSEC
2026-08-11S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-08-118-KCurrent report2026-08-11SEC
2026-08-1110-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-04SCHEDULE 13D/ASEC
2026-07-234Statement of changes in beneficial ownership of securities2026-07-23SEC
2026-07-233Initial statement of beneficial ownership of securities2026-07-23SEC
2026-07-208-KCurrent report2026-07-09SEC
2026-07-154Statement of changes in beneficial ownership of securities2026-07-14SEC
2026-07-133Initial statement of beneficial ownership of securities2026-07-01SEC
2026-06-238-KCurrent report2026-06-16SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-05-28SEC
2026-06-08144Filing for proposed sale of securities under Rule 144.SEC
2026-05-294Statement of changes in beneficial ownership of securities2026-05-28SEC
2026-05-294Statement of changes in beneficial ownership of securities2026-05-28SEC
2026-05-294Statement of changes in beneficial ownership of securities2026-05-28SEC
2026-05-294Statement of changes in beneficial ownership of securities2026-05-28SEC
2026-05-294Statement of changes in beneficial ownership of securities2026-05-28SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-1040.86K100
2026-090000
2026-0844.24K100
2026-0762.30K100
2026-060000
2026-05753.50K200
2026-04309.00K200
2026-033.64M8106.31K4
2026-0200164.10K6
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Madryn Asset Management, LP26.64%
WEXFORD CAPITAL LP2.88%
FourWorld Capital Management LLC2.51%
VANGUARD CAPITAL MANAGEMENT LLC2.17%
Lane Generational LLC1.66%
HighTower Advisors, LLC1.45%
MASTERS CAPITAL MANAGEMENT LLC1.44%
AdvisorShares Investments LLC1.21%
Ikarian Capital, LLC1.01%
BlackRock, Inc.0.86%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND1.52%
AdvisorShares Psychedelics ETF1.07%
VANGUARD EXTENDED MARKET INDEX FUND0.61%
Fidelity Small Cap Index Fund0.53%
Fidelity Nasdaq Composite Index Fund0.29%
Fidelity Extended Market Index Fund0.28%
VANGUARD RUSSELL 2000 INDEX FUND0.27%
Goldman Sachs Absolute Return Tracker Fund0.15%
Ultra-Small Company Market Fund0.14%
iShares Micro-Cap ETF0.13%

OakChart. STIM. Cached 15 minutes.